Natasha Bahri, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bahri’s office at (415) 476-0999 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A149467 · Current
Licensed to practise in California · since 2017 · expires 2027-02-28 · The Commonwealth Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$9,719 in 2023
Medicaid paid $9,719 for 94 billed services this clinician did in 2023, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 94 | $9,719 |
| 2023 | 94 | 1 | 16 | $9,719 |
| 2022 | 93 | 1 | 15 | $7,387 |
| 2021 | 171 | 1 | 16 | $12,932 |
| 2020 | 36 | 1 | 12 | $2,586 |
| 2019 | 44 | 1 | 13 | $2,858 |
| 2018 | 72 | 1 | 14 | $5,225 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 93 | $7,387 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 171 | $12,932 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 36 | $2,586 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 44 | $2,858 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 72 | $5,225 |
Drugs they prescribed that Part D paid
$133,648
Pharmacies billed $133,648 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 76) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
50 generic and 26 brand-name prescriptions · $133,648 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Exemestane | 12 | $615 | $51 |
Year by year
| 2024 | 76 | 29 | 0% (0) | 34% | $133,648 |
| 2023 | 113 | 37 | None | None | $29,080 |
| 2022 | 148 | 38 | None | None | $15,132 |
| 2021 | 106 | 34 | None | 11% | $12,722 |
| 2020 | 168 | 34 | None | None | $14,324 |
| 2019 | 135 | 36 | None | 11% | $11,580 |
| 2018 | 69 | 22 | None | None | $2,466 |
| 2017 | 95 | 23 | None | 20% | $5,229 |
| 2016 | 93 | 22 | 0% (0) | None | $1,876 |
| 2015 | 62 | 21 | None | None | $6,119 |
| 2014 | 47 | 20 | None | None | $2,571 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Acyclovir | 11 | $96 | $9 |
2022: 3 drugs
| Acyclovir | 30 | $390 | $13 |
| Levofloxacin | 12 | $188 | $16 |
| Sulfamethoxazole-Trimethoprim | 13 | $39 | $3 |
2021: 1 drug
| Acyclovir | 16 | $237 | $15 |
2020: 2 drugs
| Acyclovir | 33 | $326 | $10 |
| Sulfamethoxazole-Trimethoprim | 12 | $35 | $3 |
2019: 2 drugs
| Acyclovir | 12 | $136 | $11 |
| Sulfamethoxazole-Trimethoprim | 11 | $57 | $5 |
2017: 1 drug
| Atorvastatin | 11 | $106 | $10 |
Money from drug and device companies
$587 in 2025
| 2025 | 5 | 5 | None | $587 |
| 2024 | 8 | 11 | None | $569 |
| 2023 | 7 | 8 | None | $942 |
| 2022 | 1 | 1 | None | $135 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exelixis | Cabometyx | $175 | 1 payment
|
| Jazz Pharmaceuticals | Defitelio | $136 | 1 payment
|
| Pharmacosmos Therapeutics | Cosela | $125 | 1 payment
|
| Novartis Pharmaceuticals | Kymriah | $114 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $36 | 1 payment
|
See all 5 published payments
| Pharmacosmos Therapeutics | Meals · 2025-11-19 | Cosela | $125 |
| Jazz Pharmaceuticals | Meals · 2025-11-12 | Defitelio | $136 |
| Novartis Pharmaceuticals | Meals · 2025-11-11 | Kymriah | $114 |
| Regeneron Healthcare Solutions | Meals · 2025-10-14 | Libtayo | $36 |
| Exelixis | Meals · 2025-05-31 | Cabometyx | $175 |
See earlier years (2024, 2023, 2022)
2024: $569
| Takeda Pharmaceuticals U.S.A. | Iclusig | $160 | 2 payments
|
| Kite Pharma | Yescarta | $113 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $94 | 2 payments
|
| ADC Therapeutics America | None | $83 | 1 payment
|
| Sobi | Doptelet | $51 | 2 payments
|
| Jazz Pharmaceuticals | Defitelio | $27 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $22 | 1 payment
|
| Lilly USA | Verzenio | $20 | 1 payment
|
2023: $942
| Novartis Pharmaceuticals | Kymriah | $260 | 2 payments
|
| Alexion Pharmaceuticals | None | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $125 | 1 payment
|
| Jazz Pharmaceuticals | Vyxeos | $122 | 1 payment
|
| Pfizer | Braftovi | $114 | 1 payment
|
| Genzyme | Sarclisa | $111 | 1 payment
|
| Seagen | None | $85 | 1 payment
|
2022: $135
| AstraZeneca Pharmaceuticals LP | Calquence | $135 | 1 payment
|
Professional record
- NPI
- 1689094542
- Licence
- CA A149467California A149467: Current · expires 2027-02-28
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 505 Parnassus Ave, San Francisco, CA, 94143
- NPI first listed
- 2014-04-18
- NPI last updated
- 2019-09-17
This is when the NPI record was last certified, not a medical board exam.